1. <dd id="t14cv"><track id="t14cv"></track></dd>

        <button id="t14cv"><object id="t14cv"><input id="t14cv"></input></object></button>
        <dd id="t14cv"></dd>

        <rp id="t14cv"></rp>

      1. <rp id="t14cv"></rp>
      2. <dd id="t14cv"><pre id="t14cv"></pre></dd>

        <form id="t14cv"><tr id="t14cv"><kbd id="t14cv"></kbd></tr></form><em id="t14cv"><strike id="t14cv"><u id="t14cv"></u></strike></em>
        1. <nav id="t14cv"><sub id="t14cv"><address id="t14cv"></address></sub></nav>
          <th id="t14cv"></th>
            <dd id="t14cv"></dd>
                 
                 
                 
                 
                 
                副研究員

                姚玲 副研究員
                副研究員,博士
                E-mail: yaoling@fudan.edu.cn
                 

                      2011年畢業于上海交通大學醫學院,獲生物化學與分子生物學博士學位。畢業后任職于復旦大學附屬腫瘤醫院腫瘤研究所,乳腺癌研究所。期間于2016-2017年前往美國斯坦福大學醫學院訪問交流。主持和參加多項國家自然科學基金青年項目和面上項目,參加國家科技支撐計劃、上海市科委基礎研究項目等。研究成果發表于Nat Communication、The EMBO journal等國際核心雜志。


                研究領域:

                  1.乳腺癌相關通路分子異常剪接與乳腺癌轉移的關系;
                  2.乳腺癌相關通路分子異常表達及突變與乳腺癌發生發展的關系。


                代表性論著:

                1. Yao L#, Liu Y#, Cao Z, Li J, Huang Y, Hu X, Shao Z*. MicroRNA 493 is a prognostic factor in triple-negative breast cancer. Cancer Sci., 2018 Jul; 109(7):2294-2301.

                  Src and transformation by an RPTPalpha splice mutant found in human tumours. The EMBO journal., 2011; 30(15):3200-3211.

                2. Chen L#, Yang L#, Yao L#, Kuang XY, Zuo WJ, Li S, Qiao F, Liu YR, Cao ZG, Zhou SL, Zhou XY, Yang WT, Shi JX, Huang W, Hu X, Shao ZM*. Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients. Nat Commun., 2018 Apr 10; 9(1):1357. 

                3. Yao L#, Chi Y#, Hu X#, Li S, Qiao F, Wu J, Shao ZM*. Elevated expression of RNA methyltransferase BCDIN3D predicts poor prognosis in breast cancer. Oncotarget, 2016 Aug 16; 7(33):53895-53902.

                4. Cao ZG#, Huang YN#, Yao L#, Liu YR, Hu X, Hou YF, Shao ZM*. Positive expression of miR-361-5p indicates better prognosis for breast cancer patients. J Thorac Dis., 2016 Jul; 8(7):1772-9.

                5. Chi Y#, Yao L#, Hu X, Huang S, Huang N, Li S, Shao Z*, Wu J*. The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer. Oncotarget, 2016 Mar 22; 7(12):14951-62.

                6. Chen L, Yang L, Qiao F, Hu X, Li S, Yao L*, Yang XL, Shao ZM*. High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer. PloS One, 2015 Oct 20; 10(10):e0140572.

                7. Wang L#, Yao L#, Zheng YZ, Xu Q, Liu XP, Hu X, Wang P, Shao ZM*. Expression of autophagy-related proteins ATG5 and FIP200 predicts favorable disease-free survival in patients with breast cancer. Biochem Biophys Res Commun., 2015 Mar 20; 458(4):816-22.

                8. Li K#, Yao L#, Chen L, Cao ZG, Yu SJ, Kuang XY, Hu X, Shao ZM*. ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression. Onco Targets Ther., 2014 Jun 18; 7:1083-94.

                9. Peng WT#, Hu X#, Yao L#, Jiang YZ, Shao ZM*. Elevated expression of Girdin in the nucleus indicates worse prognosis for patients with estrogen receptor-positive breast cancer. Ann Surg Oncol., 2014 Dec; 21.

                10. 1Yao L#, Li K#, Peng W, Lin Q, Li S, Hu X, Zheng X, Shao Z*. An aberrant spliced transcript of focal adhesion kinase is exclusively expressed in human breast cancer. J Transl Med., 2014 May 21; 12:136.

                11. Huang J#, Yao L#, Xu R, Wu H, Wang M, White BS, Shalloway D, Zheng X: Activation of

                 
                復旦大學腫瘤研究所 通訊地址: 東安路270號2號樓1312室 64175590-5312 Email:fuci2012@126.com
                Copyright 2013 shca.org.cn All rights reserved. 復旦大學腫瘤研究所 版權所有
                日本AV不卡在线观看无限看片 超级黄肉动漫在线观看| 五月天在线视频国产在线| 久青草国产在视频在线观看| 色天天综合网视频网站| 亚洲国产一区二区三区| 天天做天天爱夜夜爽| 第九区在线观看免费观看| 亚洲国产一区二区三区| 亚洲日韩色欧另类欧美| 免费大香伊蕉在人线国产| 亚洲 欧美 日韩 国产 在线|